A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.
Kandhavelu J, Subramanian K, Naidoo V, Sebastianelli G, Doan P, Konda Mani S, Yapislar H, Haciosmanoglu E, Arslan L, Ozer S, Thiyagarajan R, Candeias NR, Penny C, Kandhavelu M, Murugesan A.
Kandhavelu J, et al. Among authors: murugesan a.
Br J Pharmacol. 2024 Jan;181(1):107-124. doi: 10.1111/bph.16141. Epub 2023 Sep 12.
Br J Pharmacol. 2024.
PMID: 37183661
Free PMC article.